Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in

X L Qi1, D J Stewart, H Gosselin

  • 1Department of Medicine, Montreal Heart Institute, Montreal, Quebec , Canada.

Circulation
|September 24, 1999
PubMed

Insights

Myocardial infarction impairs coronary vasodilation and heart muscle function. Captopril treatment preserves endothelial function and cardiac nitric oxide synthase, preventing these negative effects in rats.

Area of Science:

  • Cardiovascular Physiology
  • Endothelial Biology
  • Pharmacology

Background:

  • Endocardial (EE) and myocardial capillary vascular endothelial (myocap VE) cells influence myocardial contractility.
  • Myocardial infarction (MI) can lead to endothelial dysfunction and impaired cardiac function.

Purpose of the Study:

  • To evaluate endothelial-myocardial interaction in a rat post-MI model.
  • To investigate the effects of captopril on endothelial function and myocardial contractility after MI.

Main Methods:

  • Wistar rats were subjected to MI and treated with captopril or placebo.
  • Coronary vascular endothelial (VE) function was assessed using serotonin infusion in Langendorff preparations.
  • Myocardial contractile characteristics were measured in isolated papillary muscles.
  • Cardiac endothelial constitutive nitric oxide synthase (ecNOS) mRNA levels were quantified.

Main Results:

  • Post-MI, serotonin-induced coronary vasodilation was impaired but preserved with captopril.
  • Endothelial removal reduced papillary muscle tension in MI rats, indicating endothelial contribution to myocardial depression.
  • Captopril treatment prevented the reduction in cardiac ecNOS mRNA observed in untreated MI rats.

Conclusions:

  • Chronic post-MI coronary vasodilation is impaired due to endothelial dysfunction.
  • Both endocardial and myocardial capillary endothelial cells contribute to myocardial depression after infarction.
  • Captopril effectively prevents endothelial dysfunction and preserves cardiac ecNOS expression post-MI.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...